NeuroPace (NPCE) Enterprise Value (2021 - 2026)

NeuroPace has reported Enterprise Value for 6 years, with the latest figure at $493.1 million in Q2 2026.

• On a quarterly basis, Enterprise Value rose 61.14% year-over-year to $493.1 million in Q2 2026; TTM through Jun 2026 was $493.1 million, a 61.14% increase from a year earlier, with the FY2025 full-year figure at $457.3 million, up 60.71% from the prior year.
• Enterprise Value was $493.1 million for Q2 2026 at NeuroPace, up from $391.9 million in the prior quarter.
• The five-year high for Enterprise Value was $493.1 million in Q2 2026, with the low at -$40.1 million in Q4 2022.
• Average Enterprise Value over 5 years is $211.1 million, with a median of $207.2 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value slumped 177.35% in 2022, then soared 2378.34% in 2023.
• Over 5 years, Enterprise Value stood at -$40.1 million in 2022, then jumped by 649.77% to $220.4 million in 2023, then advanced by 29.11% to $284.6 million in 2024, then soared by 60.71% to $457.3 million in 2025, then climbed by 7.81% to $493.1 million in 2026.
• The last three Enterprise Value figures came in at $493.1 million (Q2 2026), $391.9 million (Q1 2026), and $457.3 million (Q4 2025), per Business Quant data.